Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
International Myeloma Working Group recommendations for diagnosis and management of solitary plasmacytomas. Note the 50% risk of progression to symptomatic myeloma within 5 years after initial definitive local radiotherapy.”
Title:MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma
Authors: Carmen Gonzalez, Camila Guerrero, Marta Larrayoz, Aintzane Zabaleta, Junfei Zhao, Ioannis V. Kostopoulos, Ourania Tsitsilonis, Evangelos Terpos, Norma C. Gutierrez, Manuela Fernandez, Maria J. José Calasanz, Paula Rodriguez-Otero, Felipe Prosper, Teresa Lozano, Juan J. Lasarte, Benjamin L. Ebert, Albert Oriol, Anna Sureda, María-Jesús Blanchard, Yolanda González-Montes, Joan Bargay, Sunil Lakhwani, Rafael Ríos-Tamayo, Laura Rosiñol, Joaquín Martínez-López, Juan-Jose Lahuerta, Joan Bladé, Maria-Victoria Mateos, Jesús San-Miguel, Maria-Teresa Cedena, Noemí Puig, Patrick Ryan Hagner, Maria Ortiz Estevez, Jose A. Martínez-Climent, Bruno Paiva
You can read the Full Article on Blood.
You can find other articles featuring Robert Orlowski on OncoDaily.
